The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Issues Warning: Compounding Certain Bulk Drug Substances May Pose Major Legal and Patient Safety Risks Lengea FDA to Review 7 Peptides for Compounding List in July 2026: BPC 157, Semax, Epitalon, and More HealingMaps An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica Is BPC 157 Legal? Understanding Its Status and Implications What are peptides? The treatments promising weight loss and better skin, explained Vox